AKERO THERAPEUTICS INC CVR from 00973Y108
13F holders, Q4 2025 (December 31)3holders
$0.00avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding AKERO THERAPEUTICS INC CVR from 00973Y108 in their 13F filings. The largest holders were Bessemer Group Inc. ($0), GAMMA Investing LLC ($0) and Keating Financial Advisory Services, Inc. ($0).
- Company
- AKERO THERAPEUTICS INC CVR from 00973Y108
- CUSIP
- 009CVR044
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $0 |
| Exits | 0 | $0 |
Ownership 3 holders
| Bessemer Group Inc. | 0.00% | New | 98 | $0 |
| GAMMA Investing LLC | 0.00% | New | 452 | $0 |
| Keating Financial Advisory Services, Inc. | 0.00% | — | 28 | $0 |
"% of holder's portfolio" is AKERO THERAPEUTICS INC CVR from 00973Y108's weight in each manager's 13F, not the share of AKERO THERAPEUTICS INC CVR from 00973Y108 the manager owns.